mTOR inhibition improves mitochondria function/biogenesis and delays cardiovascular aging in kidney transplant recipients with chronic graft dysfunction

CVD remains the major cause of mortality with graft functioning in Kidney transplant recipients (KTRs), with an estimated risk of CV events about 50-fold higher than in the general population. Many strategies have been considered to reduce the CV risk such as the use of mTOR inhibitors. We evaluate...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Aging (Albany NY)
Egile Nagusiak: Infante, Barbara, Bellanti, Francesco, Correale, Michele, Pontrelli, Paola, Franzin, Rossana, Leo, Serena, Calvaruso, Martina, Mercuri, Silvia, Netti, Giuseppe Stefano, Ranieri, Elena, Brunetti, Natale Daniele, Grandaliano, Giuseppe, Gesualdo, Loreto, Serviddio, Gaetano, Castellano, Giuseppe, Stallone, Giovanni
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals 2021
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8034974/
https://ncbi.nlm.nih.gov/pubmed/33758105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202863
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak